Άρθρα με εντολές δημόσιας πρόσβασης - IT RUBIOΜάθετε περισσότερα
Δεν είναι διαθέσιμο πουθενά: 4
The cancer stem-cell signaling network and resistance to therapy
A Carnero, Y Garcia-Mayea, C Mir, J Lorente, IT Rubio, ME LLeonart
Cancer treatment reviews 49, 25-36, 2016
Εντολές: Government of Spain
Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwide
C Are, SS Murthy, R Sullivan, M Schissel, S Chowdhury, O Alatise, ...
The Lancet Oncology 24 (12), e472-e518, 2023
Εντολές: US National Institutes of Health, Susan G. Komen
Breast-conservative surgery followed by radiofrequency ablation of margins decreases the need for a second surgical procedure for close or positive margins
IT Rubio, S Landolfi, M Molla, J Cortes, J Xercavins
Clinical breast cancer 14 (5), 346-351, 2014
Εντολές: Government of Spain
Locoregional breast cancer recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: analysis of risk factors including the 70 …
S Alaeikhanehshir, T Ajayi, FH Duijnhoven, C Poncet, RO Olaniran, ...
Journal of Clinical Oncology 42 (10), 1124-1134, 2024
Εντολές: Cancer Research UK
Διαθέσιμο κάπου: 32
70-gene signature as an aid to treatment decisions in early-stage breast cancer
F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ...
New England Journal of Medicine 375 (8), 717-729, 2016
Εντολές: US National Institutes of Health, Cancer Research UK, Dutch Cancer Society …
PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition
YH Ibrahim, C García-García, V Serra, L He, K Torres-Lockhart, A Prat, ...
Cancer discovery 2 (11), 1036-1047, 2012
Εντολές: US National Institutes of Health
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
F Cardoso, JMS Bartlett, L Slaets, CHM Van Deurzen, ...
Annals of Oncology 29 (2), 405-417, 2018
Εντολές: US National Institutes of Health, Susan G. Komen
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
C Cruz, M Castroviejo-Bermejo, S Gutiérrez-Enríquez, A Llop-Guevara, ...
Annals of Oncology 29 (5), 1203-1210, 2018
Εντολές: US National Institutes of Health, Cancer Research UK, European Commission …
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
M Piccart, LJ van't Veer, C Poncet, JMNL Cardozo, S Delaloge, JY Pierga, ...
The Lancet Oncology 22 (4), 476-488, 2021
Εντολές: Cancer Research UK, Dutch Cancer Society, Susan G. Komen
A RAD 51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
M Castroviejo‐Bermejo, C Cruz, A Llop‐Guevara, S Gutiérrez‐Enríquez, ...
EMBO molecular medicine 10 (12), e9172, 2018
Εντολές: US National Institutes of Health, Canadian Institutes of Health Research …
The requirements of a specialist breast centre
L Biganzoli, F Cardoso, M Beishon, D Cameron, L Cataliotti, CE Coles, ...
The Breast 51, 65-84, 2020
Εντολές: National Institute for Health Research, UK
The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phase
E Rutgers, MJ Piccart-Gebhart, J Bogaerts, S Delaloge, L Van‘t Veer, ...
European journal of cancer 47 (18), 2742-2749, 2011
Εντολές: US National Institutes of Health, Cancer Research UK
Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy
WP Weber, M Haug, C Kurzeder, V Bjelic-Radisic, R Koller, R Reitsamer, ...
Breast cancer research and treatment 172, 523-537, 2018
Εντολές: US National Institutes of Health, Swiss Cancer Foundation, Swiss Cancer League
p95HER2–T cell bispecific antibody for breast cancer treatment
I Rius Ruiz, R Vicario, B Morancho, CB Morales, EJ Arenas, S Herter, ...
Science translational medicine 10 (461), eaat1445, 2018
Εντολές: US National Institutes of Health, Government of Spain
European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission
M Lawler, L Davies, S Oberst, K Oliver, A Eggermont, A Schmutz, ...
The Lancet Oncology 24 (1), e11-e56, 2023
Εντολές: Cancer Research UK, UK Medical Research Council, National Institute for …
Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients
M Ahmed, F Jozsa, R Baker, IT Rubio, J Benson, M Douek
Breast cancer research and treatment 166, 329-336, 2017
Εντολές: A*Star, Singapore, UK Medical Research Council, Wellcome Trust, Human …
Patterns of HER2 gene amplification and response to anti-HER2 therapies
R Vicario, V Peg, B Morancho, M Zacarias-Fluck, J Zhang, ...
PloS one 10 (6), e0129876, 2015
Εντολές: Government of Spain
Effect of cellular senescence on the growth of HER2-positive breast cancers
MF Zacarias-Fluck, B Morancho, R Vicario, A Luque Garcia, ...
Journal of the National Cancer Institute 107 (5), djv020, 2015
Εντολές: Government of Spain
Effect of p95HER2/611CTF on the response to trastuzumab and chemotherapy
JL Parra-Palau, B Morancho, V Peg, M Escorihuela, M Scaltriti, R Vicario, ...
Journal of the National Cancer Institute 106 (11), dju291, 2014
Εντολές: US National Institutes of Health, Government of Spain
Intra-operative electron radiation therapy: an update of the evidence collected in 40 years to search for models for electron-FLASH studies
FA Calvo, J Serrano, M Cambeiro, J Aristu, JM Asencio, I Rubio, ...
Cancers 14 (15), 3693, 2022
Εντολές: Government of Spain
Τα στοιχεία έκδοσης και χρηματοδότησης καθορίζονται αυτόματα από ένα πρόγραμμα υπολογιστή